Psyence Biomedical Ltd
PBM
View Detailed Chart
2.812USD
-0.988-26.01%
Market hours （ET）Quotes delayed by 15 min
842.18KMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-26.01%
5 Days
+324.22%
1 Month
+251.90%
6 Months
+19.14%
Year to Date
+273.20%
1 Year
-77.53%
View Detailed Chart
TradingKey Stock Score
No stock score available due to insufficient data.
Psyence Biomedical Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Psyence Biomedical Ltd Info
Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
Ticker SymbolPBM
CompanyPsyence Biomedical Ltd
CEOMaresky (Neil)
Website
Related Instruments
-4.10%
-1.01%
+1.68%
+0.14%
+2.75%
-0.42%
-0.94%
+1.55%
-12.74%
-3.73%
-1.51%
+0.66%
+0.75%
+1.13%
+0.56%
-0.38%
+0.34%
0.00%
+0.09%
-1.55%Popular Symbols
270.305
+0.295 (+0.11%)
179.550
-6.060 (-3.26%)
74507.430
-3461.210 (-4.44%)
289.338
+19.108 (+7.07%)
2137.810
-181.350 (-7.82%)
419.095
-2.715 (-0.64%)
4937.410
+285.690 (+6.14%)
62.733
+0.733 (+1.18%)
1.182
+0.003 (+0.23%)
155.715
+0.132 (+0.08%)
